All Insights

Banking and finance

Why isn't every loan sustainability linked in the UK?

Reassessing sustainability-linked loans for UK mid-market dealmakers
OC Ventures

OC Ventures Update | November 2024

Welcome to the latest edition of the OC Ventures update
Corporate

Navigating earn-outs: bridging valuation gaps in M&A transactions

Earn-out provisions offer a compromise in M&A deals, tying part of the purchase price to future performance and addressing valuation
Corporate

The EU Listing Act: what are the key changes to the Prospectus Regulation?

The Listing Act aims to simplify obligations and procedures to enhance the attractiveness of EU capital markets
Corporate

FCA issues additional guidance on inside information under UK Market Abuse Regulation

The guidance covers, among other things, the definition of inside information, disclosure and communications with shareholders
ESG – Environmental, Social and Governance

ESG Knowledge Update | November 2024

Welcome to our Osborne Clarke ESG Knowledge Update, which offers a round-up of legal, regulatory and market news
Life Sciences and Healthcare

Investment control in transactions in the life sciences and healthcare sector

Investment control means that additional regulatory approvals are required, affecting the timeline, complexity and costs of a transaction
Corporate

UK directors' duties: IOD issues guidance on the importance of sustainable business practice

New voluntary code of conduct provides helpful steer to directors – especially with regard to 'responsible business'
Life Sciences and Healthcare

Life sciences dealmakers need to anticipate sector-specific factors in European M&A

European regulatory and intellectual property complexities must be addressed when engaging in mergers and acquisitions
Corporate

UK Takeover Panel confirms refocusing of the scope of City Code

Finalised amendments to the jurisdictional framework of the Takeover Code will streamline its applicability